Back
Crinetics Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$48.77
Seasonality Move:
-13.46%
7 Day Trial
ALL ACCESS PASS
$
7
Crinetics Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 17.9% based on the past 7 years of stock performance.
-
Crinetics Pharmaceuticals, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Crinetics Pharmaceuticals, Inc. Stock Undervalued?The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $48.87. The Score for CRNX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 17.9% based on the past 7 years of stock performance.
Crinetics Pharmaceuticals, Inc. Stock Rating
Sell
39
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. overpriced?
-
Crinetics Pharmaceuticals, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Crinetics Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
54.78
52-Week Low:
24.10
Prediction Charts
Market Cap:
4.6B
Price in USD:
48.87
Volume:
1.1M
Beta:
0.68
Technical Analysis
SMA50:
44.47
SMA100:
39.55
SMA200:
35.46
52-Wk Change:
-9.43%
Stock Predictions
-
Is Crinetics Pharmaceuticals, Inc. stock public?Yes, Crinetics Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Crinetics Pharmaceuticals, Inc. stock quote today?The Crinetics Pharmaceuticals, Inc. stock price is 48.87 USD today.
-
How to buy Crinetics Pharmaceuticals, Inc. stock online?You can buy Crinetics Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 46.83 | 47.42 | 48.62 | 46.63 |
| Dec-5 | 47.52 | 46.67 | 47.83 | 46.65 |
| Dec-8 | 46.85 | 47.40 | 49.29 | 46.85 |
| Dec-9 | 47.07 | 47.90 | 49.26 | 46.49 |
| Dec-10 | 47.90 | 48.06 | 48.59 | 47.43 |
| Dec-11 | 48.54 | 49.31 | 50.08 | 48.19 |
| Dec-12 | 49.00 | 50.49 | 50.98 | 48.58 |
| Dec-15 | 50.71 | 49.32 | 50.93 | 49.27 |
| Dec-16 | 49.78 | 48.61 | 50.19 | 48.36 |
| Dec-17 | 48.97 | 47.69 | 49.14 | 47.40 |
| Dec-18 | 47.34 | 45.14 | 47.98 | 43.04 |
| Dec-19 | 45.31 | 48.01 | 49.00 | 45.07 |
| Dec-22 | 47.87 | 49.24 | 49.75 | 47.56 |
| Dec-23 | 48.81 | 48.87 | 49.40 | 48.61 |
Crinetics Pharmaceuticals, Inc. Earnings
Crinetics Pharmaceuticals, Inc. Earnings Report: Per Share Crinetics Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals, Inc. Forecast Revenue Growth
Crinetics Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.25 per share, and a decrease next year of $0.27 per share.
* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.